LINC02277

Across TCGA pan-cancer cohorts, LINC02277 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC02277’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02277 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02277 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and UCEC are the cancer types where LINC02277 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02277 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	III,IV	−0.126	.010	4	view →
LUSC	All	All	−0.057	.010	2	view →
UCEC	All	All	+0.052	.042	2	view →
KIRC	All	All	−0.010	.034	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC02277–LUAD

Open the LUAD breakdown →